07-07-2025 21:45
via
medscape.com
Will Mifepristone Prove a CATALYST for Change?
Treatment with mifepristone results in clinically meaningful improvements in HbA1c and cardiometabolic risk in patients with difficult-to-control T2D and hypercortisolism.Medscape Diabetes & Endocrinology
Read more »
Nurse news
Experts Define On-Treatment Remission for Plaque Psoriasis
A DNA Test for Every Newborn: Smart or Premature?
Langer: Synthetic Biology is Here and It’s Changing Lives
Can Long COVID Be Decoded?
Palpitations: A 12-Lead EKG Doesn’t Tell the Full Story
Key Updates in AxSpA From EULAR 2025
Study: Rx Delayed in Half of US Children With Vitiligo
Think Glass Bottles Are Safer? Think Again
AxSpA Maintained OK via Remote Monitoring, Patient-Led Care
RDEB: Large Wounds Healed With Genetically Corrected Grafts
Autoimmune Skin Diseases Tied to Better Cancer Survival
Semaglutide Has Found Its STRIDE
How Do Front-of-Package Warnings Influence People?
Endocrine Insights: Thyroid Management Tips for PCPs
Desktop versie